Category: Pfizer

A.M. Vitals: Pizza and cholesterol drugs, psychiatric meds and campaign promises

MEwens
A tie in the statin wars: Cholesterol fighter Crestor, considered by some doctors to be the most potent statin, didn’t fare significantly better than rival Lipitor, a new study finds. The results, presented at the American Heart Association’s meeting, will make it harder for Crestor’s maker AstraZeneca to convince payors that the drug […]

Continued Read ...

Pharma Mystery Theater: Teva and generic Lipitor

MEwens
The world’s biggest selling drug of all time — the cholesterol medicine Lipitor — goes generic at the end of the month. Will the world’s leading maker of generic drugs be selling no-name Lipitor pills?
A lot of tongues are wagging.
Lipitor loses U.S. patent protection Nov. 30. Selling generic versions is a big prize, […]

Continued Read ...
Posted in Drugs, Generics, Pfizer  

All Drug Marketing Is Local

MEwens
When a Pfizer sales representative came to his hospital last year pitching the pain drug Lyrica, Dr. Hiroshi Nishino pressed for details — he wanted to know just how the drug works on a molecular level.
“I’d want to try a new drug with a different mechanism of action because” that might give it an […]

Continued Read ...
Posted in Drugs, Global, Pfizer  

A.M. Vitals: Cancer Death Rates Falling

Avery Johnson
 
Cancer rates: Lung-cancer death rates for women fell for the first time in four decades as the overall cancer death rates kept declining, Dow Jones Newswires reports.
Despite the overall positive trend, one negative was an increased incidence of childhood cancer, according to a report in the Journal of the National Cancer Institute. […]

Continued Read ...
Posted in Cancer, Pfizer, J&J  

Laid-Off Pfizer Researchers Will Get Less Generous Severance

MEwens
The company stopped offering a more generous severance package at the end of last year.
Read more this great post here

Continued Read ...
Posted in Research, Pfizer  

The Bottom Line on Why Pfizer Bought Wyeth

Katherine Hobson
Pfizer’s results — and management’s rosy outlook — depended heavily on Wyeth.
Read more this great post here

Continued Read ...
Posted in Drugs, M&A, Pfizer  

Pfizer to Pay $3.6 Billion for King Pharmaceuticals

Katherine Hobson
King’s products include new formulations of pain treatments, an emergency drug delivery business and an animal health business.
Read more this great post here

Continued Read ...
Posted in Drugs, M&A, Pfizer  

Steel Cage Match: Advil vs. Tylenol Edition

MEwens
Pfizer announced Monday that it’s giving away 500,000 free bottles of Advil to people who clear their medicine cabinet of expired or recalled medicines.
Read more this great post here

Continued Read ...
Posted in Drugs, Advertising, Pfizer, J&J  

Pfizer Wants to Be the IBM of Animal Health

Avery Johnson
Growth in the animal health market is expected to continue at 5% growth for coming years.
Read more this great post here

Continued Read ...
Posted in Pfizer  

Genzyme and Pfizer, Kissin’ in a Tree? Probably Not.

Katherine Hobson
Pfizer CFO said on an earnings call with analysts that his company is looking for acquisitions worth between a few billion to several billion dollars.
Read more this great post here

Continued Read ...
Posted in M&A, Pfizer  

Next Page »

 
Google
Web ekstrapalma.com

RSS Health Care Blog News